Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Christophe

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Blood|August 7, 2019
Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophiliaKaren Aymonnier, Charlotte Kawecki, Laurence Venisse, et al.
Hemasphere|May 8, 2026
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoformsGeneviève McCluskey, Hortense Maynadié, Delphine Borgel, et al.
Blood|April 10, 2014
Expression of a structurally constrained von Willebrand factor variant triggers acute thrombotic thrombocytopenic purpura in miceYoko Morioka, Caterina Casari, Nikolett Wohner, et al.
Blood|August 16, 2013
Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopeniaCaterina Casari, Vivian Du, Ya-Ping Wu, et al.
Blood|April 15, 2024
Fitusiran reduces bleeding in factor X-deficient miceSebastien Verhenne, Geneviève McCluskey, Hortense Maynadié, et al.
Journal of Virology|July 4, 2001
Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latencyC Merezak, C Pierreux, E Adam, et al.
Thrombosis and Haemostasis|October 23, 2019
A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia AVincent Muczynski, Sebastien Verhenne, Caterina Casari, et al.
Gene Therapy|January 18, 2021
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factorElena Barbon, Charlotte Kawecki, Solenne Marmier, et al.
Blood|February 19, 2017
Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactionsVincent Muczynski, Gabriel Aymé, Véronique Regnault, et al.
Bone Research|March 12, 2026
Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male miceAntoine Babuty, Javier Muñoz-Garcia, Olivier D Christophe, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Blood|August 7, 2019
Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophiliaKaren Aymonnier, Charlotte Kawecki, Laurence Venisse, et al.
Hemasphere|May 8, 2026
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoformsGeneviève McCluskey, Hortense Maynadié, Delphine Borgel, et al.
Blood|April 10, 2014
Expression of a structurally constrained von Willebrand factor variant triggers acute thrombotic thrombocytopenic purpura in miceYoko Morioka, Caterina Casari, Nikolett Wohner, et al.
Blood|August 16, 2013
Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopeniaCaterina Casari, Vivian Du, Ya-Ping Wu, et al.
Blood|April 15, 2024
Fitusiran reduces bleeding in factor X-deficient miceSebastien Verhenne, Geneviève McCluskey, Hortense Maynadié, et al.
Journal of Virology|July 4, 2001
Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latencyC Merezak, C Pierreux, E Adam, et al.
Thrombosis and Haemostasis|October 23, 2019
A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia AVincent Muczynski, Sebastien Verhenne, Caterina Casari, et al.
Gene Therapy|January 18, 2021
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factorElena Barbon, Charlotte Kawecki, Solenne Marmier, et al.
Blood|February 19, 2017
Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactionsVincent Muczynski, Gabriel Aymé, Véronique Regnault, et al.
Bone Research|March 12, 2026
Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male miceAntoine Babuty, Javier Muñoz-Garcia, Olivier D Christophe, et al.
Pageof 15